KPC Pharmaceuticals Inc Cash Flow Conversion Efficiency
KPC Pharmaceuticals Inc cash flow conversion efficiency. Based on the latest financial reports, KPC Pharmaceuticals Inc (600422) has a cash flow conversion efficiency ratio of 0.016x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥113.07 Million ≈ $16.55 Million USD) by net assets (CN¥6.94 Billion ≈ $1.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of KPC Pharmaceuticals Inc (1999–2025)
Cash flow conversion efficiency of KPC Pharmaceuticals Inc from 1999 to 2025. This chart illustrates how KPC Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 600422 live share price for real-time trading data and today's change.
KPC Pharmaceuticals Inc Cash Flow Conversion Ratio Explained
KPC Pharmaceuticals Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
KPC Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of KPC Pharmaceuticals Inc ranked by their cash flow conversion efficiency. Also see KPC Pharmaceuticals Inc market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Leedarson IoT Technology Inc
SHG:605365
|
-0.025x |
|
thyssenkrupp nucera AG & Co. KGaA
XETRA:NCH2
|
0.020x |
|
Malakoff Corporation Bhd
KLSE:5264
|
0.021x |
|
Plejd AB (publ)
F:3CA
|
0.115x |
|
Jinzi Ham Co Ltd
SHE:002515
|
-0.006x |
|
INVEX Controladora S.A.B. de C.V
MX:INVEXA
|
-0.566x |
|
Universal Corporation
NYSE:UVV
|
-0.082x |
|
Elopak AS
OL:ELO
|
0.153x |
Annual Cash Flow Conversion Efficiency for KPC Pharmaceuticals Inc (1999–2025)
The table below shows the annual cash flow conversion efficiency of KPC Pharmaceuticals Inc from 1999 to 2025. Review KPC Pharmaceuticals Inc free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥6.94 Billion ≈ $1.02 Billion |
CN¥289.24 Million ≈ $42.32 Million |
0.042x | -65.21% |
| 2024-12-31 | CN¥6.75 Billion ≈ $987.19 Million |
CN¥808.07 Million ≈ $118.25 Million |
0.120x | +26.31% |
| 2023-12-31 | CN¥7.95 Billion ≈ $1.16 Billion |
CN¥754.33 Million ≈ $110.38 Million |
0.095x | +92.08% |
| 2022-12-31 | CN¥5.14 Billion ≈ $752.51 Million |
CN¥253.90 Million ≈ $37.15 Million |
0.049x | -3.07% |
| 2021-12-31 | CN¥4.94 Billion ≈ $722.92 Million |
CN¥251.63 Million ≈ $36.82 Million |
0.051x | -42.81% |
| 2020-12-31 | CN¥4.60 Billion ≈ $673.51 Million |
CN¥409.94 Million ≈ $59.99 Million |
0.089x | -10.12% |
| 2019-12-31 | CN¥4.33 Billion ≈ $634.22 Million |
CN¥429.50 Million ≈ $62.85 Million |
0.099x | +11.14% |
| 2018-12-31 | CN¥3.95 Billion ≈ $577.79 Million |
CN¥352.07 Million ≈ $51.52 Million |
0.089x | +38.74% |
| 2017-12-31 | CN¥3.77 Billion ≈ $552.21 Million |
CN¥242.53 Million ≈ $35.49 Million |
0.064x | -25.39% |
| 2016-12-31 | CN¥3.61 Billion ≈ $528.55 Million |
CN¥311.16 Million ≈ $45.53 Million |
0.086x | -39.71% |
| 2015-12-31 | CN¥3.34 Billion ≈ $488.14 Million |
CN¥476.62 Million ≈ $69.74 Million |
0.143x | -22.76% |
| 2014-12-31 | CN¥2.05 Billion ≈ $299.93 Million |
CN¥379.13 Million ≈ $55.48 Million |
0.185x | +43.65% |
| 2013-12-31 | CN¥1.88 Billion ≈ $274.98 Million |
CN¥241.97 Million ≈ $35.41 Million |
0.129x | -36.22% |
| 2012-12-31 | CN¥1.06 Billion ≈ $154.63 Million |
CN¥213.33 Million ≈ $31.22 Million |
0.202x | +32.09% |
| 2011-12-31 | CN¥917.52 Million ≈ $134.26 Million |
CN¥140.24 Million ≈ $20.52 Million |
0.153x | +38.02% |
| 2010-12-31 | CN¥820.15 Million ≈ $120.01 Million |
CN¥90.82 Million ≈ $13.29 Million |
0.111x | -36.41% |
| 2009-12-31 | CN¥738.35 Million ≈ $108.04 Million |
CN¥128.57 Million ≈ $18.81 Million |
0.174x | +27.48% |
| 2008-12-31 | CN¥670.50 Million ≈ $98.12 Million |
CN¥91.59 Million ≈ $13.40 Million |
0.137x | -33.29% |
| 2007-12-31 | CN¥635.17 Million ≈ $92.94 Million |
CN¥130.06 Million ≈ $19.03 Million |
0.205x | +95.19% |
| 2006-12-31 | CN¥583.86 Million ≈ $85.44 Million |
CN¥61.25 Million ≈ $8.96 Million |
0.105x | +135.35% |
| 2005-12-31 | CN¥588.02 Million ≈ $86.05 Million |
CN¥-174.52 Million ≈ $-25.54 Million |
-0.297x | -7626.53% |
| 2004-12-31 | CN¥723.20 Million ≈ $105.83 Million |
CN¥-2.78 Million ≈ $-406.50K |
-0.004x | -104.14% |
| 2003-12-31 | CN¥659.95 Million ≈ $96.57 Million |
CN¥61.23 Million ≈ $8.96 Million |
0.093x | +204.86% |
| 2002-12-31 | CN¥571.17 Million ≈ $83.58 Million |
CN¥17.38 Million ≈ $2.54 Million |
0.030x | -74.60% |
| 2001-12-31 | CN¥559.74 Million ≈ $81.91 Million |
CN¥67.07 Million ≈ $9.81 Million |
0.120x | +39.91% |
| 2000-12-31 | CN¥557.64 Million ≈ $81.60 Million |
CN¥47.76 Million ≈ $6.99 Million |
0.086x | -79.96% |
| 1999-12-31 | CN¥140.93 Million ≈ $20.62 Million |
CN¥60.24 Million ≈ $8.81 Million |
0.427x | -- |
About KPC Pharmaceuticals Inc
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, comether tablets, specialty herbal products, classic prescription for bones and joint, ant… Read more